Scholarlink

<p>The influence of sex differences on the clinical prognosis of patients with non-ST-elevation myocardial infarction (NSTEMI) remains controversial. This multicenter, retrospective study analyzed NSTEMI patients from five institutions.&#xa0;The primary endpoints were major adverse cardiac and cerebrovascular events (MACCE) and major adverse cardiac events (MACE). Multivariate logistic regression was used to assess sex differences in revascularization. Multivariate Cox regression with stepwise selection identified independent prognostic predictors. Stratified analyses were performed by revascularization status.&#xa0;To strengthen the analytical robustness, propensity score matching (PSM) was employed as a sensitivity analysis, balancing age, comorbidities, and key treatment factors. A total of 4,911 NSTEMI patients (3,506 men; 1,405 women) completed follow-up. Women were less likely to undergo revascularization (adjusted odds ratio 0.68, 95%CI 0.58–0.79). Over a median follow-up of 527&#xa0;days, women had significantly lower cumulative survival free from MACCE and MACE (both <i>P</i> &lt; 0.001). After multivariate adjustment, women remained to have an increased risk of MACCE (HR 1.20, 95% CI 1.03–1.40) and MACE (HR 1.30, 95% CI 1.09–1.55) in the overall cohort, particularly among those not undergoing revascularization (MACCE: HR 1.30, 95% CI 1.05–1.60; MACE: HR 1.64, 95% CI 1.27–2.10). However, no significant sex-based differences were observed in the revascularized subgroup (<i>P</i> &gt; 0.05). These findings were consistent in the PSM-based sensitivity analysis. The sex-based prognosis difference in NSTEMI is linked to underutilization of revascularization in women. Ensuring equitable guideline-directed revascularization may eliminate this disparity.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Impact of sex differences on revascularization and long-term clinical outcomes in patients with non-ST-elevation myocardial infarction: a multicentre study from China

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月9日

查看全文
  • Chongyou Rao,
  • Qin Zhong,
  • Wuhong Zhou,
  • Zongren Li,
  • Liqiang Fu,
  • Wei Liu,
  • Wei Qin,
  • Jixian Gao,
  • Bo Liu,
  • Kunlun He,
  • Feihu Zhou

摘要

The influence of sex differences on the clinical prognosis of patients with non-ST-elevation myocardial infarction (NSTEMI) remains controversial. This multicenter, retrospective study analyzed NSTEMI patients from five institutions. The primary endpoints were major adverse cardiac and cerebrovascular events (MACCE) and major adverse cardiac events (MACE). Multivariate logistic regression was used to assess sex differences in revascularization. Multivariate Cox regression with stepwise selection identified independent prognostic predictors. Stratified analyses were performed by revascularization status. To strengthen the analytical robustness, propensity score matching (PSM) was employed as a sensitivity analysis, balancing age, comorbidities, and key treatment factors. A total of 4,911 NSTEMI patients (3,506 men; 1,405 women) completed follow-up. Women were less likely to undergo revascularization (adjusted odds ratio 0.68, 95%CI 0.58–0.79). Over a median follow-up of 527 days, women had significantly lower cumulative survival free from MACCE and MACE (both P < 0.001). After multivariate adjustment, women remained to have an increased risk of MACCE (HR 1.20, 95% CI 1.03–1.40) and MACE (HR 1.30, 95% CI 1.09–1.55) in the overall cohort, particularly among those not undergoing revascularization (MACCE: HR 1.30, 95% CI 1.05–1.60; MACE: HR 1.64, 95% CI 1.27–2.10). However, no significant sex-based differences were observed in the revascularized subgroup (P > 0.05). These findings were consistent in the PSM-based sensitivity analysis. The sex-based prognosis difference in NSTEMI is linked to underutilization of revascularization in women. Ensuring equitable guideline-directed revascularization may eliminate this disparity.